Peer Review History
| Original SubmissionNovember 20, 2024 |
|---|
|
PONE-D-24-53272Association between physical activity level and cardiovascular disease: an empirical analysis based on CHARLS data in 2018PLOS ONE Dear Dr. Li, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that this study has merits and it really adds to the existing literature, but needs some major revisions before publication. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please kindly address the comments raised by our peer reviewers, especially on following aspects:1. Statistical anlayis: Adjusting for key confounders2. Explanation on generalizability of your findings3. Proper referencing 4. Use of standard and intelligible language in the manuscript Please submit your revised manuscript by Apr 17 2025 11:59PM. If you will need more time to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Bishnu Deep Pathak, MBBS Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Funding Section of your manuscript: “The study was financially supported by the Shanxi Province Philosophy and Social Science Planning Project (NO. 2020YY080). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.” We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “HL was supported by the Shanxi Province Philosophy and Social Science Planning Project (No. 2020YY080). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. We note that there is identifying data in the Supporting Information file < S2 File-data.xls>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I read the manuscript titled “Association between physical activity level and cardiovascular disease: an empirical analysis based on CHARLS data in 2018” by Haiwei Li and colleagues with special interest. This study reported significant correlation between prevalence of CVD and physical activity level. I congratulate authors for reporting their significant findings. I don’t have major comments however I have small comment in regards to the manuscript. The referencing is not per the PLOS style and ref 23 authors name is somehow not correctly listed therefore would recommend to revisit the authors guideline (https://journals.plos.org/plosone/s/submission-guidelines) and proof read them as mentioned in the guideline “ In the text, cite the reference number in square brackets (e.g., “We used the techniques developed by our colleagues [19] to analyze the data”)”. Reviewer #2: Feedback for Authors This study investigates the association between physical activity levels (PAL) and cardiovascular disease (CVD) among middle-aged and elderly individuals in China using data from the 2018 China Health and Retirement Longitudinal Study (CHARLS). The study presents a valuable epidemiological analysis, highlighting a significant inverse relationship between PAL and CVD prevalence. The use of a large, nationally representative dataset strengthens its relevance, and the application of multivariate logistic regression and restricted cubic spline models enhances its methodological rigor. However, several major revisions are required to improve the robustness, clarity, and interpretability of the findings. The main concerns revolve around (1) methodological limitations, (2) confounding adjustments, (3) self-reported CVD diagnosis, (4) PAL categorization, and (5) discussion of causality and generalizability. Addressing these issues will enhance the validity and impact of the study. General Comments - Methodological Limitations: Cross-sectional Design & Causality The study employs a cross-sectional design, yet much of the discussion implies a causal relationship between PAL and CVD risk reduction. The wording throughout the manuscript should be tempered to avoid causal inferences. Statements such as “higher PAL reduces CVD risk” should be modified to indicate an association rather than causality. A clearer acknowledgment of reverse causality is necessary. Individuals with CVD may engage in less physical activity due to disease-related limitations, leading to an overestimation of the association. The discussion should explicitly recognize this issue and suggest prospective studies to confirm the findings. - Confounding Factors and Model Adjustments The multivariate analysis lacks adjustment for key confounders, including hypertension, diabetes, hyperlipidemia, smoking, alcohol consumption, and BMI—all of which are strong predictors of CVD and could mediate the association with PAL. Without adjusting for these critical variables, it remains unclear whether the observed association is due to PAL itself or reflects a clustering of other healthier lifestyle behaviors in the high PAL group. The authors should include additional confounders in the regression models or justify why these variables were excluded. The impact of social and economic status (which may influence both PAL and access to healthcare) should be discussed more explicitly as a potential source of residual confounding. - Self-Reported CVD Diagnosis: Accuracy & Bias The diagnosis of CVD is based on self-reported physician-diagnosed heart disease or stroke. This method is prone to recall bias and may lead to misclassification errors. Participants with undiagnosed CVD or those with subjective symptoms but no formal diagnosis may be misclassified. The sensitivity and specificity of self-reported CVD data should be addressed in the discussion, and comparisons with objectively measured CVD prevalence in similar populations should be provided if available. - PAL Categorization and MET-Minute Thresholds The classification of low, moderate, and high PAL is based on arbitrary MET-minute cutoffs (<600, 600-3000, >3000 MET-min/week). However, it is unclear whether these categories align with established guidelines such as WHO, ACSM, or AHA recommendations. Justification should be provided for the chosen MET cutoffs. Alternatively, the analysis could be repeated using quartiles or deciles of PAL to explore whether different thresholds yield different results. The interpretation of 3000 MET-min/week as a threshold for reduced CVD prevalence should be critically examined, as it does not align directly with WHO recommendations for physical activity. - Restricted Cubic Spline Interpretation The restricted cubic spline analysis suggests a linear inverse association between PAL and CVD (p > 0.05 for non-linearity). However, Figure 2 should be more clearly annotated to indicate where the confidence intervals widen, which could suggest statistical uncertainty at extreme PAL levels. The authors should discuss whether this linear trend holds across all PAL levels or whether the association plateaus at higher MET levels, as some studies suggest diminishing returns beyond a certain point. - Generalizability & Population-Specific Considerations The study is based on Chinese middle-aged and elderly individuals, and lifestyle patterns may differ significantly from Western populations. The discussion should explicitly address the external validity of the findings and whether they can be generalized to younger individuals, different ethnic groups, or non-Asian populations. Urban-rural differences in occupational physical activity should also be discussed, as many rural participants may engage in high PAL due to labor-intensive work rather than structured exercise. Detailed Comments Abstract The phrase “high PAL reduces CVD risk” should be changed to “high PAL is associated with a lower CVD prevalence.” The sample size (9015 participants) should be explicitly stated in the methods section of the abstract. Introduction The introduction effectively highlights the importance of PAL, but it oversimplifies the causal relationship. Statements such as "maintaining >3000 MET-min/week reduces CVD risk" should be softened to "is associated with lower CVD prevalence." Methods Multivariable model adjustments: Include key covariates such as hypertension, diabetes, smoking, alcohol consumption, and BMI. Clarify PAL measurement: Was PAL derived solely from self-reported surveys, or were objective measurements (e.g., accelerometers) available? Describe how missing data were handled: Was multiple imputation used, or were missing cases excluded? Results Table 1: Add p-values for baseline characteristics to indicate whether significant differences exist between groups. Table 3: Clarify whether PAL was modeled as a categorical or continuous variable in the logistic regression. Discussion Causality: Strengthen the acknowledgment of reverse causality and residual confounding. Confounding bias: Explicitly discuss the lack of adjustment for key clinical variables such as hypertension, smoking, and diabetes. Dose-response relationship: Discuss whether there is a plateau effect for high PAL levels. Generalizability: Address whether findings are applicable to younger or non-Chinese populations. Figures & Tables Figure 2: Add confidence interval shading to highlight the uncertainty at extreme PAL levels. Table 3: Consider including effect sizes (ORs) for additional quartiles or deciles of PAL instead of only three broad categories. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-24-53272R1Association between physical activity level and cardiovascular disease: an empirical analysis based on CHARLS data in 2018PLOS ONE Dear Dr. Li, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 14 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Amirmohammad Khalaji Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: No comments as manuscript is throughly revised and all comments addressed as appropriate by authors. I applaud for their work Reviewer #2: Weaknesses (Major issues): Handling of residual confounding (especially socioeconomic status) is insufficiently robust. The definition of PAL categories (low, moderate, high) remains somewhat arbitrary despite partial justification. Some new additions (e.g., quartile analyses) are insufficiently integrated into the discussion. The narrative on plateau effects in the dose-response relationship needs more depth. Figure 2 still lacks enough annotation to guide readers in interpreting wide confidence intervals. Detailed Comments Introduction Good improvement on causal language. However, some remaining sentences still sound too causal (e.g., “maintaining moderate-to-high physical activity reduces the burden of CVD”). Please revise consistently to “associated with”. Methods Exposure Measurement: The reliance solely on self-reported PAL should be more critically discussed upfront. Objective measures (e.g., accelerometers) are unavailable, but the authors could mention this as a limitation in the Methods itself (not only in Discussion). Missing Data Handling: The handling of missing data was by case-wise deletion. Given the substantial exclusions (over 10,000 participants), please add a sensitivity analysis or at least discuss the potential for selection bias more explicitly in the Discussion section. Covariate Selection: While education and household consumption were used as proxies for socioeconomic status (SES), the absence of an explicit SES composite variable is a concern. Discuss this more clearly. Alternatively, re-analyze with household consumption quintiles or categories if possible. Results Figure 2 (Restricted Cubic Spline): While the figure is technically correct, the wide confidence intervals at high PAL (>12,000 MET-min/week) and low PAL (<600 MET-min/week) need explicit labels or annotations. Suggest adding dotted vertical lines at 600, 3000, and 10,000 MET-minutes/week to show thresholds. Briefly describe in the Results section when the OR curve begins to plateau (currently mixed into the Discussion only). Discussion Residual Confounding: The potential for residual confounding (especially unmeasured variables like diet, medication adherence, genetic factors) should be acknowledged. Current references suggesting minimal misclassification for self-reported CVD are appreciated but still optimistic; please explicitly note that this might not fully apply to the Chinese CHARLS cohort. Plateau Effect: You mention a plateau at >10,000 MET-min/week, but the biological plausibility and comparison to other cohort studies (e.g., PURE, UK Biobank) should be discussed. Also, briefly speculate on whether very high levels of activity might confer risks (overtraining, cardiovascular stress). Generalizability: Good discussion on urban/rural differences and cultural factors. It would be helpful to strengthen the point that findings might not apply to populations where leisure-time physical activity (rather than occupational activity) predominates. Minor Points Proofreading is still needed: Fix minor English grammar issues (e.g., "the confidence intervals wide" → "the confidence intervals widened"). Consistent tenses (prefer "was/were" rather than "is/are" when describing past data). ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Association between physical activity level and cardiovascular disease: an empirical analysis based on CHARLS data in 2018 PONE-D-24-53272R2 Dear Dr. Li, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Amirmohammad Khalaji Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: This manuscript represents a valuable and well-conducted epidemiological study examining the association between physical activity and cardiovascular disease in a large, nationally representative Chinese cohort. The authors have addressed prior reviewer comments in depth, improving the manuscript substantially. The analyses are robust, the discussion is thoughtful, and the public health relevance is clear. While limitations remain—especially the cross-sectional design and self-reported data—the strengths outweigh these issues. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-24-53272R2 PLOS ONE Dear Dr. Li, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Amirmohammad Khalaji Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .